| Literature DB >> 21515427 |
Jenny Petering1, Patrick McManamny, Jane Honeyman.
Abstract
The antibody patent landscape has evolved dramatically over the past 30 years, particularly in areas of technology relating to antibody modification to reduce immunogenicity in humans or improve antibody function. In some cases antibody techniques that were developed in the 1980s are still the subject of patent protection in the United States or Canada.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21515427 DOI： 10.1016/j.nbt.2011.03.023
Source DB: PubMed Journal: N Biotechnol ISSN： 1871-6784 Impact factor: 5.079